Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 May;164 Suppl 1(Suppl 1):7-10.
doi: 10.1111/j.1365-2249.2011.04357.x.

Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener's granulomatosis)

Affiliations
Review

Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener's granulomatosis)

J C Jennette. Clin Exp Immunol. 2011 May.

Abstract

Names influence how something is perceived. Diagnostic terms (diagnoses) are the names of diseases that are usually derived either from some distinctive characteristic of the disease or include an eponym recognizing someone who elucidated the disease. No matter how logical and appropriate a name may be, if it is not usable and used it is of no lasting value. This brief commentary focuses on the nomenclature of systemic vasculitides, and uses as a prime example Wegener's granulomatosis, which has been renamed recently 'granulomatosis with polyangiitis', in part because of concerns about the suitability of Friedrich Wegener as the source of an eponym. The most distinctive pathological feature of Wegener's granulomatosis is multi-focal necrotizing inflammation that has long been called granulomatosis. The systemic variant of Wegener's granulomatosis also is characterized by inflammation in many different vessels or different types, i.e. polyangiitis. Thus, granulomatosis with polyangiitis is a very appropriate alternative term for Wegener's granulomatosis. This term also is in accord with the name for a closely related vasculitis, i.e. microscopic polyangiitis. Terms that indicate aetiology and pathogenesis, when known, are useful to include in names for diseases (diagnoses). Anti-neutrophil cytoplasmic autoantibodies specific for myeloperoxidase (MPO-ANCA) or proteinase 3 (PR3-ANCA) are implicated in the cause of granulomatosis with polyangiitis and thus also should be specified in the diagnosis (e.g. PR3-ANCA-positive granulomatosis with polyangiitis or MPO-ANCA-positive microscopic polyangiitis). As our understanding of the clinical manifestations, pathogenesis and aetiology of vasculitides change over time, the names and approaches for diagnosing these diseases will change accordingly.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Frequency of the use of the term ‘microscopic polyarteritis’versus‘microscopic polyangiitis’ in the title of articles in PubMed from 1990 to 2010. Graph (a) expresses this as the total number of articles published per year. Graph (b) expresses this as a percentage of all articles that had either term in the title. Note the change in usage after publication of the recommendations of the Chapel Hill Consensus Conference (CHCC) in 1994.
Fig. 2
Fig. 2
Photomicrographs of an acute necrotizing lesion in the lung of a patient with granulomatosis with polyangiitis (GPA) (Wegener's granulomatosis) showing a central zone of necrosis with intense influx of neutrophils (microabscess formation) with an adjacent multi-nucleated giant cell: arrow in (a). The higher magnification in (b) reveals a phagocytosed neutrophil (small arrow) and phagocytosed apoptotic debris (large arrow) in the cytoplasm of a multi-nucleated giant cell (haematoxylin and eosin stain).
Fig. 3
Fig. 3
Photomicrographs of the edge of a necrotizing lesion in the lung of a patient with granulomatosis with polyangiitis (GPA) (Wegener's granulomatosis) showing a zone of necrosis in the lower right with a marginal band of palisading elongated macrophages (arrows) in the upper left (haematoxylin and eosin stain).

References

    1. Falk RJ, Jennette JC. ANCA disease: where is this field going? J Am Soc Nephrol. 2010;21:745–52. - PubMed
    1. Falk RJ, Gross WL, Guillevin L, et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. 2011. A joint proposal of the American College of Rheumatology, the American Society of Nephrology, and the European League against Rheumatism, in press. - PubMed
    1. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92. - PubMed
    1. Woywodt A, Haubitz M, Haller H, Matteson EL. Wegener's granulomatosis. Lancet. 2006;367:1362–6. - PubMed
    1. Wegener F. Ueber eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und der Nieren. About a peculiar rhinogenic granulomatosis with marked involvement of the arterial system and kidneys. 1939;102:30–68.

MeSH terms